Molecular imaging developer Sofie Biosciences said it has received a $1 million grant from the U.S. Department of Energy (DoE).
The phase II grant has been awarded under the Small Business Innovation Research (SBIR) program and will support Sofie's development of a microscale technology for synthesizing new PET probes, according to the firm.
Presently, scientists and clinicians must accept the limitations of the centralized radiopharmacy model of PET probe production and distribution, where a limited number of probes are available from radiochemistry cores or, more often, commercial radiopharmacies that provide an even smaller menu from which to choose, Sofie said.
